Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcela F Pasetti

Showing results (141-150 of 172) with videos related to

Pageof 18
Sort By:
Journal of the Pediatric Infectious Diseases Society|August 17, 2023
Durable Anti-Vi IgG and IgA Antibody Responses in 15-Month-Old Children Vaccinated With Typhoid Conjugate Vaccine in Burkina FasoAlphonse Ouedraogo, Amidou Diarra, Issa Nébié, et al.
Msphere|July 14, 2016
ASM Journals Eliminate Impact Factor Information from Journal WebsitesArturo Casadevall, Stefano Bertuzzi, Michael J Buchmeier, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 11, 2026
Humoral Response to COVID-19 Vaccines and Infection During Sibeprenlimab Treatment of IgA Nephropathy: Data from the ENVISION TrialKieran McCafferty, Jonathan Barratt, Yusuke Suzuki, et al.
Plos One|March 3, 2016
Immunization Coverage Surveys and Linked Biomarker Serosurveys in Three Regions in EthiopiaMark A Travassos, Berhane Beyene, Zenaw Adam, et al.
Msystems|November 9, 2016
ASM Journals Eliminate Impact Factor Information from Journal WebsitesArturo Casadevall, Stefano Bertuzzi, Michael J Buchmeier, et al.
The Lancet. Infectious Diseases|August 19, 2018
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled studyWilbur H Chen, Kathleen M Neuzil, C Rebecca Boyce, et al.
Biologicals : Journal of the International Association of Biological Standardization|June 24, 2020
Evaluation of a standardised Vi poly-l-lysine ELISA for serology of Vi capsular polysaccharide antibodiesPeter Rigsby, Emma Beamish, Jason Hockley, et al.
The Journal of Infectious Diseases|February 8, 2024
Recombinant Full-length Plasmodium falciparum Circumsporozoite Protein-Based Vaccine Adjuvanted With Glucopyranosyl Lipid A-Liposome Quillaja saponaria 21: Results of Phase 1 Testing With Malaria ChallengeDeAnna J Friedman-Klabanoff, Andrea A Berry, Mark A Travassos, et al.
Science Translational Medicine|May 14, 2025
An oral norovirus vaccine generates mucosal immunity and reduces viral shedding in a phase 2 placebo-controlled challenge studyBecca A Flitter, Joshua Gillard, Susan N Greco, et al.
Vaccine|October 9, 2013
Safety and tolerability of a live oral Salmonella typhimurium vaccine candidate in SIV-infected nonhuman primatesAlida Ault, Sharon M Tennant, J Patrick Gorres, et al.
Pageof 18

Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
Journal of the Pediatric Infectious Diseases Society|August 17, 2023
Durable Anti-Vi IgG and IgA Antibody Responses in 15-Month-Old Children Vaccinated With Typhoid Conjugate Vaccine in Burkina FasoAlphonse Ouedraogo, Amidou Diarra, Issa Nébié, et al.
Msphere|July 14, 2016
ASM Journals Eliminate Impact Factor Information from Journal WebsitesArturo Casadevall, Stefano Bertuzzi, Michael J Buchmeier, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 11, 2026
Humoral Response to COVID-19 Vaccines and Infection During Sibeprenlimab Treatment of IgA Nephropathy: Data from the ENVISION TrialKieran McCafferty, Jonathan Barratt, Yusuke Suzuki, et al.
Plos One|March 3, 2016
Immunization Coverage Surveys and Linked Biomarker Serosurveys in Three Regions in EthiopiaMark A Travassos, Berhane Beyene, Zenaw Adam, et al.
Msystems|November 9, 2016
ASM Journals Eliminate Impact Factor Information from Journal WebsitesArturo Casadevall, Stefano Bertuzzi, Michael J Buchmeier, et al.
The Lancet. Infectious Diseases|August 19, 2018
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled studyWilbur H Chen, Kathleen M Neuzil, C Rebecca Boyce, et al.
Biologicals : Journal of the International Association of Biological Standardization|June 24, 2020
Evaluation of a standardised Vi poly-l-lysine ELISA for serology of Vi capsular polysaccharide antibodiesPeter Rigsby, Emma Beamish, Jason Hockley, et al.
The Journal of Infectious Diseases|February 8, 2024
Recombinant Full-length Plasmodium falciparum Circumsporozoite Protein-Based Vaccine Adjuvanted With Glucopyranosyl Lipid A-Liposome Quillaja saponaria 21: Results of Phase 1 Testing With Malaria ChallengeDeAnna J Friedman-Klabanoff, Andrea A Berry, Mark A Travassos, et al.
Science Translational Medicine|May 14, 2025
An oral norovirus vaccine generates mucosal immunity and reduces viral shedding in a phase 2 placebo-controlled challenge studyBecca A Flitter, Joshua Gillard, Susan N Greco, et al.
Vaccine|October 9, 2013
Safety and tolerability of a live oral Salmonella typhimurium vaccine candidate in SIV-infected nonhuman primatesAlida Ault, Sharon M Tennant, J Patrick Gorres, et al.
Pageof 18